sodium perborate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4777 10332-33-9

Description:

MoleculeDescription

Synonyms:

  • sodium perborate
  • sodium perborate monohydrate
  • Molecular weight: 199.62
  • Formula: B2H4Na2O8
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Gastrointestinal toxicity 184.95 74.02 40 1169 7701 63480112
Pulmonary toxicity 176.98 74.02 40 1169 9415 63478398
Joint injury 131.74 74.02 40 1169 29532 63458281
Neoplasm malignant 131.36 74.02 40 1169 29821 63457992
Hepatotoxicity 122.87 74.02 40 1169 37001 63450812
Joint stiffness 118.06 74.02 40 1169 41829 63445984
C-reactive protein abnormal 99.09 74.02 36 1173 46060 63441753
Therapy non-responder 94.89 74.02 40 1169 75861 63411952
Musculoskeletal pain 87.38 74.02 40 1169 92237 63395576
Therapeutic product effect incomplete 75.82 74.02 40 1169 125016 63362797

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Gastrointestinal toxicity 111.04 66.60 24 841 8085 79735438
Pulmonary toxicity 99.92 66.60 24 841 12890 79730633
Joint injury 78.84 66.60 24 841 31311 79712212
Neoplasm malignant 78.48 66.60 24 841 31786 79711737
Joint stiffness 72.59 66.60 24 841 40806 79702717
Hepatotoxicity 67.20 66.60 24 841 51328 79692195

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A01AB19 ALIMENTARY TRACT AND METABOLISM
STOMATOLOGICAL PREPARATIONS
STOMATOLOGICAL PREPARATIONS
Antiinfectives and antiseptics for local oral treatment
CHEBI has role CHEBI:132717 bleaching agent

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D07066 KEGG_DRUG
4020415 VUID
N0000148205 NUI
7632-04-4 SECONDARY_CAS_RN
4020415 VANDF
CHEBI:30178 CHEBI
CHEMBL3707333 ChEMBL_ID
C027707 MESH_SUPPLEMENTAL_RECORD_UI
Y52BK1W96C UNII
1991500 RXNORM
NOCODE MMSL
003159 NDDF
387434009 SNOMEDCT_US
725753000 SNOMEDCT_US
7624002 SNOMEDCT_US
C0074750 UMLSCUI
517072 PUBCHEM_CID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Amosan Oral Wound Cleanser HUMAN OTC DRUG LABEL 1 71223-001 POWDER, FOR SOLUTION 1.20 g TOPICAL OTC monograph not final 12 sections
Amosan Oral Wound Cleanser HUMAN OTC DRUG LABEL 1 71223-001 POWDER, FOR SOLUTION 1.20 g TOPICAL OTC monograph not final 12 sections
Amosan Oral Wound Cleanser HUMAN OTC DRUG LABEL 1 71223-001 POWDER, FOR SOLUTION 1.20 g TOPICAL OTC monograph not final 12 sections
Amosan Wound CleanserCherry Flavour HUMAN OTC DRUG LABEL 1 71223-002 POWDER, FOR SOLUTION 1.20 g ORAL OTC monograph not final 12 sections
Amosan Wound CleanserCherry Flavour HUMAN OTC DRUG LABEL 1 71223-002 POWDER, FOR SOLUTION 1.20 g ORAL OTC monograph not final 12 sections